Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Strecker

Showing results (101-110 of 126) with videos related to

Pageof 13
Sort By:
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
MMWR. Morbidity and Mortality Weekly Report|November 21, 2014
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014Aditya Sharma, Nico Heijenberg, Clement Peter, et al.
Journal of Virology|September 8, 2017
IRF9 Prevents CD8<sup>+</sup> T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus InfectionMagdalena Huber, Tamara Suprunenko, Thomas Ashhurst, et al.
The New England Journal of Medicine|January 7, 2016
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus DiseaseEtienne Gignoux, Andrew S Azman, Martin de Smet, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
The Journal of Infectious Diseases|November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in HumansJoseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Nature Communications|May 16, 2024
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in GuineaJoseph Akoi Boré, Joseph W S Timothy, Tom Tipton, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Pageof 13

Showing results (101-110 of 126) with videos related to

Sort By:
Pageof 13
Cell Reports|September 7, 2024
Defining bottlenecks and opportunities for Lassa virus neutralization by structural profiling of vaccine-induced polyclonal antibody responsesPhilip J M Brouwer, Hailee R Perrett, Tim Beaumont, et al.
MMWR. Morbidity and Mortality Weekly Report|November 21, 2014
Evidence for a decrease in transmission of Ebola virus--Lofa County, Liberia, June 8-November 1, 2014Aditya Sharma, Nico Heijenberg, Clement Peter, et al.
Journal of Virology|September 8, 2017
IRF9 Prevents CD8<sup>+</sup> T Cell Exhaustion in an Extrinsic Manner during Acute Lymphocytic Choriomeningitis Virus InfectionMagdalena Huber, Tamara Suprunenko, Thomas Ashhurst, et al.
The New England Journal of Medicine|January 7, 2016
Effect of Artesunate-Amodiaquine on Mortality Related to Ebola Virus DiseaseEtienne Gignoux, Andrew S Azman, Martin de Smet, et al.
Biorxiv : the Preprint Server for Biology|July 9, 2024
A broadly-neutralizing antibody against <i>Ebolavirus</i> glycoprotein that potentiates the breadth and neutralization potency of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
The Journal of Infectious Diseases|November 20, 2018
Detectable Vesicular Stomatitis Virus (VSV)-Specific Humoral and Cellular Immune Responses Following VSV-Ebola Virus Vaccination in HumansJoseph H Poetsch, Christine Dahlke, Madeleine E Zinser, et al.
Nature Communications|May 16, 2024
Serological evidence of zoonotic filovirus exposure among bushmeat hunters in GuineaJoseph Akoi Boré, Joseph W S Timothy, Tom Tipton, et al.
Cell Reports|May 20, 2023
Structural conservation of Lassa virus glycoproteins and recognition by neutralizing antibodiesHailee R Perrett, Philip J M Brouwer, Jonathan Hurtado, et al.
Ebiomedicine|April 25, 2017
Dose-dependent T-cell Dynamics and Cytokine Cascade Following rVSV-ZEBOV ImmunizationChristine Dahlke, Rahel Kasonta, Sebastian Lunemann, et al.
Npj Viruses|May 7, 2026
A broadly-neutralizing antibody against Orthoebolavirus glycoprotein that potentiates the breadth and neutralization of other antibodiesFrancesca R Donnellan, Vamseedhar Rayaprolu, Pramila Rijal, et al.
Pageof 13